胃肠间质瘤临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 胃肠间质瘤（国际通用名 gastrointestinal stromal tumor）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖GIST等说法。
正在招募的胃肠间质瘤新药试验
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
II 期招募中美国澳大利亚加拿大中国NCT06760819Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
不适用招募中中国NCT05751733Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
不适用招募中MexicoNCT06523582A Study of Olverembatinib in SDH-deficient GIST.
III 期招募中中国NCT06640361Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
II 期招募中中国NCT04933669Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
I 期招募中美国NCT07171203A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
II 期招募中法国NCT05152472Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)
II 期招募中法国NCT05009927Imatinib TDM in GIST
II 期招募中美国NCT05493215Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
II 期 / III 期招募中中国South KoreaNCT07379047Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study
不适用招募中NetherlandsNCT07522762Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments
I 期招募中日本NCT07618377
胃肠间质瘤试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。